|Last Price$34.86||Day Change (%)-0.14%|
|Open Price$35.11||Day Change ($)-0.05|
|Day Range33.93–35.37||52-Week Range22.30–42.96|
As of Fri 03/07/2014 04:25 PM EST | USD
Theravance THRX reported second-quarter earnings that matched our expectations, and we are keeping our fair value estimate at $29 per share. The company continues to make progress in each of its programs, namely the addition of a second Phase IIb compound in the Beyond Advair trials and completion ...